Search clinical trials for: LKA651

Total 3 results

Novartis Pharmaceuticals

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Diabetic Macular Edema | Macular Edema | Neovascular Age-related Macular Degeneration | Retinal Vein Occlusions

Puerto Rico, United States
Novartis Pharmaceuticals

Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Diabetic Macular Edema

Germany, Turkey, United States, Spain, Puerto Rico
Alcon Research
Novartis Institutes for BioMedical Research

Withdrawn

A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema

Diabetic Macular Edema

3

Subscribe